Hypertension emergencies and urgencies

Sudeep Kumar , Tanuj Bhatia , Aditya Kapoor
{"title":"Hypertension emergencies and urgencies","authors":"Sudeep Kumar ,&nbsp;Tanuj Bhatia ,&nbsp;Aditya Kapoor","doi":"10.1016/j.cqn.2013.01.004","DOIUrl":null,"url":null,"abstract":"<div><p>Where at one hand, the vast majority of hypertensive patients succumb to the complications of hypertension like atherosclerosis, cerebrovascular diseases and congestive heart failure, a subset of these have an exacerbation in this gradual course that needs acute management in the blood pressure control and plays a role in short term outcomes. These hypertensive crises are now encountered more frequently, in more diverse and aging population than in earlier times.</p><p>Despite the recognized unmet need of timely evaluation and management, fewer than 10% receive the recommended investigations and appropriate treatment often gets delayed. This review emphasizes the therapeutic implications of correct diagnosis, various treatment options and targets in different clinical circumstances.</p><p>Nicardipine, clevidipine, esmolol and fenoldopam have emerged as potentially superior drugs in most hypertensive emergencies as compared to other conventional drugs. For hypertensive urgencies, blood pressure lowering at a gradual pace with oral drugs &amp; adequate follow up are two important facets of management, making sure that the blood pressure has been lowered out of a potentially dangerous range.</p><p>Impact of optimal management of hypertensive crisis should translate into lesser target organ damage and eventually fewer complications of stroke, myocardial infarction, or congestive heart failure.</p></div>","PeriodicalId":100275,"journal":{"name":"Clinical Queries: Nephrology","volume":"2 1","pages":"Pages 1-14"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cqn.2013.01.004","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Queries: Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211947713000083","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Where at one hand, the vast majority of hypertensive patients succumb to the complications of hypertension like atherosclerosis, cerebrovascular diseases and congestive heart failure, a subset of these have an exacerbation in this gradual course that needs acute management in the blood pressure control and plays a role in short term outcomes. These hypertensive crises are now encountered more frequently, in more diverse and aging population than in earlier times.

Despite the recognized unmet need of timely evaluation and management, fewer than 10% receive the recommended investigations and appropriate treatment often gets delayed. This review emphasizes the therapeutic implications of correct diagnosis, various treatment options and targets in different clinical circumstances.

Nicardipine, clevidipine, esmolol and fenoldopam have emerged as potentially superior drugs in most hypertensive emergencies as compared to other conventional drugs. For hypertensive urgencies, blood pressure lowering at a gradual pace with oral drugs & adequate follow up are two important facets of management, making sure that the blood pressure has been lowered out of a potentially dangerous range.

Impact of optimal management of hypertensive crisis should translate into lesser target organ damage and eventually fewer complications of stroke, myocardial infarction, or congestive heart failure.

高血压紧急情况和紧急情况
一方面,绝大多数高血压患者死于高血压的并发症,如动脉粥样硬化、脑血管疾病和充血性心力衰竭,其中一部分在这个渐进的过程中会加剧,需要在血压控制方面进行急性管理,并在短期内发挥作用。与早期相比,这些高血压危象在更加多样化和老龄化的人口中更加频繁地出现。尽管认识到及时评估和管理的需求尚未得到满足,但只有不到10%的人接受了建议的检查,适当的治疗往往被推迟。这篇综述强调了在不同的临床情况下正确诊断、各种治疗方案和靶点的治疗意义。尼卡地平、克利维地平、艾司洛尔和非诺dopam在大多数高血压紧急情况下,与其他常规药物相比,已成为潜在的优越药物。对于高血压急症,口服药物逐渐降低血压;适当的随访是管理的两个重要方面,确保血压降至潜在危险范围之外。高血压危象的最佳管理应该转化为更少的靶器官损害,并最终减少卒中、心肌梗死或充血性心力衰竭的并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信